http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2229520-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-13 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 |
| filingDate | 2002-11-05^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-05-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da2f32c1281a7e5fd710972418516ee0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1da3a86e59d13f2a75d5fa1554fa7c79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a9f194676027527d570a67644bb210b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_366d52a696a4e91074fd6f4e5def2b1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd10d0e5692b7083ce5e6790dc297379 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bb3aab88aa2227fc4a03d1aa6d88716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eae5762d04e06483ebf1ff12e42a7a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad5cdcb3945ce7fb3aa84474919aee15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c9059dc93b0a6ec38b53e42f5a186b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdac2b91da34da73ac252ad9aa0904dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77f933c34bc87f489c1a089c915aa2e9 |
| publicationDate | 2004-05-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2229520-C1 |
| titleOfInvention | Cyclodecapeptide antibiotic laterocidin with broad spectrum of antagonistic effect, strain of bacterium brevibacillus laterosporus eliciting broad spectrum of antagonistic effect as producer of antibiotic laterocidin |
| abstract | FIELD: antibiotics, biotechnology, microbiology. SUBSTANCE: invention relates to manufacturing the novel antibiotic laterocidin. Laterocidin shows antagonistic effect against bacteria, cyanobacteria, phytopathogenic fungi and protozoa. Laterocidin is a cyclodecapeptide antibiotic and represents white amorphous substance of the formula: [cyclo-(L-Val-L-Om-L-Leu-D-Tyr-L-Pro-L-Phe-D-Phe-L-Asn-L-Asp-L-Leu)] and molecular mass 1224.4 Da. Producer of laterocidin is the strain of bacterium Brevibacillus laterosporus that is obtained from the natural strain of the same species as result of multi-step selection. The strain is deposited at number VKPEM B-8287. The strain shows activity against series of Gr + and Gr - microorganisms, phytopathogenic fungi and protozoa microorganisms. Application of the strain and laterocidin provides expanding the assortment of antagonists with broad spectrum of effect. EFFECT: valuable medicinal properties of antibiotic. 3 cl, 4 tbl, 8 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2701502-C1 |
| priorityDate | 2002-11-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 117 of 117.